SCHEMBL8778923

SCHEMBL8778923

O=C1c2c(cccc2OCc2ccccc2)CCC12CCCC2

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 5/20 0.41
HTR2A P28223 5/20 0.41
HTR2C P28335 5/20 0.41
HTR2B P41595 5/20 0.41
SIGMAR1 Q99720 5/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
MAPT P10636 1/20 0.41
MAPK1 P28482 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
RXRB P28702 5/20 0.41
RXRA P19793 4/20 0.41
RXRG P48443 3/20 0.41
BRD4 O60885 2/20 0.40
CREBBP Q92793 1/20 0.40
OPRK1 P41145 1/20 0.40
OPRL1 P41146 1/20 0.40
ALPG P10696 1/20 0.40
PTK2B Q14289 1/20 0.40
MRGPRX4 Q96LA9 1/20 0.39
HTT P42858 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8778939 0.85 MAPT (0.41) DRD2L3MBTL1MAPTMAPK1TDP1
SCHEMBL34466766 0.81 MAPT (0.45) DRD2L3MBTL1MAPTMAPK1TDP1
SCHEMBL8779044 0.80 HTT (0.52) DRD2HTR2AHTR2CHTR2BSIGMAR1
SCHEMBL7280823 0.77 MAOA (0.53) L3MBTL1MAPTMAPK1TDP1RXRB
SCHEMBL16844582 0.76 MAPT (0.49) DRD2L3MBTL1MAPTMAPK1TDP1
SCHEMBL8779017 0.73 MAOB (0.63) SMN1; SMN2MAOB
SCHEMBL8778993 0.73 MAOB (0.63) DRD2HTR2AHTR2CHTR2BSIGMAR1
SCHEMBL30769168 0.72 MAOB (0.65) SMN1; SMN2MAOB
SCHEMBL29473827 0.72 MAPT (0.50) DRD2L3MBTL1MAPTMAPK1TDP1
SCHEMBL16388131 0.72 MAPT (0.50) DRD2L3MBTL1MAPTMAPK1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0606661-B1 Octahydrophenanthrene derivatives and their use as NMDA-Antagonists HOFFMANN LA ROCHE (CH) 1997-03-12 EP disclosed
US-5385947-A For prevention of nerve damage due to reduction of blood or oxygen supplies HOFFMANN-LA ROCHE INC. (US) 1995-01-31 US disclosed
EP-0606661-A1 Octahydrophenanthrene derivatives and their use as NMDA-Antagonists F. HOFFMANN-LA ROCHE AG (CH) 1994-07-20 EP disclosed